PMA - Standard Reagent for THP1 Cell Differentiation

THP1 cell differentiation

Phorbol 12-myristate 13-acetate (PMA), also known as 12-O-tetradecanoylphorbol-13-acetate or TPA, is a naturally occurring phorbol ester found in plants like croton oil.

PMA is commonly used to activate protein kinase C (PKC), a family of enzymes involved in various cellular processes such as cell growth, differentiation, proliferation and apoptosis (programmed cell death). PMA can activate all isoforms of PKC, but it has a particularly strong affinity for PKCα, PKCε and PKCδ. PMA-activated PKC can phosphorylate a variety of target proteins, including transcription factors, signaling molecules and cytoskeletal proteins. PKC is a critical component of many signaling pathways and its activation can lead to a cascade of intracellular events.

  • Cell growth and differentiation: PMA can promote cell growth and differentiation by activating PKC. This effect is thought to be mediated by the activation of genes that promote cell growth and differentiation.
  • Apoptosis: PMA can also induce apoptosis or programmed cell death. This effect is thought to be mediated by the activation of genes that promote apoptosis.
  • Cancer: PMA is a known tumor promoter. This means that it can increase the risk of cancer by promoting cell growth and differentiation.
  • Inflammation: PMA can induce inflammation. This effect is thought to be mediated by the activation of genes that promote inflammation.

Figure: THP1 cell differentiation into macrophages using PMA.

 

Differentiation of THP-1 Cells

The human monocytic cell line, THP-1, is the most widely used cell line for in vitro studies investigating primary human macrophage function.  The reason is that following the differentiation of THP-1 cells using PMA, they acquire a macrophage-like phenotype, which mimics in many respects, primary human macrophages (M0 macrophages). PMA is a potent activator of protein kinase C (PKC), which is a key regulator of macrophage differentiation. When PMA is added to THP-1 cells, it causes them to express the surface markers CD14, CD16 and CD68, which are characteristic of M0 macrophages. PMA also induces the production of pro-inflammatory cytokines by M0 macrophages. Further treatment with PMA can activate M0 macrophages and differentiate them into M1 or M2 macrophages. 

Activation of M0 Macrophages

M0 macrophages are a type of macrophages that are not yet fully activated. They are characterized by their expression of a variety of surface markers, including CD14, CD16 and CD68. M0 macrophages are also able to produce a variety of cytokines, including IL-1β, IL-6 and TNF-α.

Addition of PMA M0 macrophages activates them through PKC activation. Consequently, activated M0 macrophages undergo a number of changes, including, the increased expression of pro-inflammatory cytokines, increased production of reactive oxygen species, increased phagocytic activity and increased migration.

  • PMA can induce the differentiation of M0 macrophages into M1 macrophages, which are pro-inflammatory cells that play a role in fighting infection.
  • PMA can also induce the differentiation of M0 macrophages into M2 macrophages, which are anti-inflammatory cells that play a role in tissue repair.
  • PMA can increase the production of reactive oxygen species by M0 macrophages, which can help to kill bacteria and other pathogens.
  • PMA can increase the phagocytic activity of M0 macrophages, which allows them to engulf and destroy foreign particles.
  • PMA can increase the migration of M0 macrophages, which allows them to travel to the site of infection or injury.

The differentiation of THP-1 cells into M0 macrophages is a complex process, important for the immune response to infection and injury.

Figure: THP-1 cells differentiation into M0 macrophages.

Literature References:

  1. In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: part 1: P.M. Blumberg; Crit. Rev. Toxicol. 8, 153 (1980)

  2. In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: part 2: P.M. Blumberg; Crit. Rev. Toxicol. 8, 199 (1981)

  3. The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus: M.E. Lund, et al.; J. Immunol. Methods 430, 64 (2016)

  4. Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFNγ+LPS), M(IL-4) and M(IL-10) phenotypes: E.W. Baxter, et al.; J. Immunol. Methods 478, 112721 (2020)


Phorbol 12-myristate 13-acetate (PMA)

Other names: TPA; 12-O-Tetradecanoylphorbol 13-acetate

PMA is the most common phorbol. It is a potent tumor promoter and highly inflammatory in nature. It is a potent activator of protein kinase C (PKC), a family of enzymes that play a role in many cellular processes, including cell growth, differentiation and apoptosis. It is a standard reagent for THP1 cell differentiation.

AG-CN2-0010  (1 mg, 5 mg, 10 mg, 25 mg, BULK) 


    AdipoGen Life Sciences is an original Manufacturer of high-purity PMA. BULK quantities are available from Stock!


    Product Specifications:

    CAS:       16561-29-8
    Source:   Semisynthetic
    Purity:     >98% HPLC
    Identity:  Determined by 1H-NMR


    Contact us at info@adipogen.com and inquire about BULK Pricing!

       PMA


    Small Molecule PKC Agonists/Inducers/Activators

    Product Name PID Product Description
    Ingenol-3-angelate (I3A) AG-CN2-0012 Specific PKC activator.
    Phorbol 12-myristate 13-acetate (PMA) AG-CN2-0010 Potent PKC activator.

    PKC Antagonist/Inhibitor/Blocker

    Product Name PID Product Description
    Staurosporine AG-CN2-0022 Potent, cell permeable, reversible, ATP-competitive broad spectrum PKC antagonist.
    Bisindolylmaleimide I AG-CR1-0009 Cell permeable, selective PKC inhibitor (Ki = 10 nM).
    Bisindolylmaleimide I . hydrochloride AG-CR1-0110 Cell permeable, selective PKC inhibitor (Ki = 10 nM), water soluble.
    Bisindolylmaleimide II AG-CR1-0010 PKC antagonist.
    Bisindolylmaleimide III AG-CR1-0112 Potent and selective PKC inhibitor.
    Bisindolylmaleimide IV AG-CR1-0152 Cell permeable PKC inhibitor.
    Bisindolylmaleimide VIII . acetate AG-CR1-0114 Selective PKC inhibitor.
    Bisindolylmaleimide IX . methanesulfonate AG-CR1-0111 Selective, cell permeable PKC inhibitor.
    Bisindolylmaleimide X . hydrochloride AG-CR1-0113 Selective PKC inhibitor.
    Bisindolylmaleimide XI . hydrochloride AG-CR1-0109 Selective cell permeable PKC inhibitor.
    Calphostin C AG-CN2-0430 Potent, highly specific, cell permeable, light-dependent PKC antagonist.


    Negative Controls for PKC Modulators

    Product Name PID Product Description
    Bisindolylmaleimide V AG-CR1-0023 Negative control for PKC inhibitors.
    4α-Phorbol 12-myristate 13-acetate AG-CN2-0082 Negative control for phorbol ester activation of PKC and studies with PMA.

    © 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.